Valensa on astaxanthin dispute with Cyanotech: ‘It is disappointing it has come to this’
It is “disappointing” that two key players in the astaxanthin market have ended up talking via their attorneys after their “excellent business relationship” became frayed, Valensa International president Dr Rudi Moerck has admitted.